Oliveira, M., Accordino, M. K., Cervantes, A., Gambardella, V., Hamilton, E. P., Italiano, A., Jhaveri, K. L., Juric, D., Kalinsky, K., Krop, I. E., Saura, C., Schmid, P., Turner, N. C., Varga, A., Jin, Y., Lim, S., Royer-Joo, S., Shankar, N., Schutzman, J., Bedard, P. (2025). Phase I/Ib study of inavolisib (INAVO) alone and in combination with endocrine therapy ± palbociclib (PALBO) in patients (pts) with
            <i>PIK3CA</i>
            -mutated, hormone receptor–positive, HER2-negative locally advanced/metastatic breast cancer (HR+, HER2– LA/mBC): Analysis of hyperglycemia (HG) in prediabetic/obese pts.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.1004